Patents by Inventor Christoph Umbricht

Christoph Umbricht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PSMA-binding agents and uses thereof
    Patent number: 11629201
    Abstract: The present invention provides novel compounds that are useful as radiopharmaceuticals, imaging agents and for treatment of cancer.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: April 18, 2023
    Assignees: ITM Isotope Technologies Munich SE, Paul Scherrer Institut
    Inventors: Martina Benesova, Cristina Müller, Christoph Umbricht, Roger Schibli, Konstantin Zhernosekov
  • NOVEL TUMOR ANTIGEN BINDING AGENTS AND USES THEREOF
    Publication number: 20220024882
    Abstract: The present invention provides compounds according to General Formula (1)(i) or (1)(ii): wherein A is a diagnostic or therapeutic agent comprising a binding site for a tumor antigen, and the spacer comprises at least one C—N bond.
    Type: Application
    Filed: November 28, 2019
    Publication date: January 27, 2022
    Inventors: Martina Benesova, Cristina Müller, Christoph Umbricht, Roger Schibli, Konstantin Zhernosekov, Luisa Maria Deberle
  • NOVEL PSMA-BINDING AGENTS AND USES THEREOF
    Publication number: 20210009715
    Abstract: The present invention provides novel compounds that are useful as radiopharmaceuticals, imaging agents and for treatment of cancer.
    Type: Application
    Filed: May 24, 2018
    Publication date: January 14, 2021
    Inventors: Martina Benesova, Cristina Müller, Christoph Umbricht, Roger Schibli, Konstantin Zhernosekov